Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Save
100203 50 µg ¥7,920
100204 500 µg ¥26,440
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  2. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  3. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  4. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  5. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  6. Zaman R, et al. 2021. Immunity. :. PubMed
  7. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  8. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  9. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  10. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  11. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  12. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  13. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  14. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  15. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  16. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  17. Gawish R, et al. 2022. Elife. 11:. PubMed
  18. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  19. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  20. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  21. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  22. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  23. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  24. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  25. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  26. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  27. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  28. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  29. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  30. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  31. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  32. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  33. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  34. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  35. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  36. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  37. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  38. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  39. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  40. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  41. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  42. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  43. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  44. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  45. Diao L, et al. 2022. iScience. 25:105511. PubMed
  46. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  47. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  48. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  49. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  50. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  51. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  52. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  53. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  54. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  55. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  56. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  57. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  58. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  59. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  60. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  61. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  62. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  63. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  64. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  65. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  66. White C, et al. 2014. J Immunol. 193:5933. PubMed
  67. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  68. Deng P, et al. 2022. Cells. 11:. PubMed
  69. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  70. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  71. Solanki A, et al. 2018. Development. 145. PubMed
  72. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  73. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  74. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  75. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  76. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  77. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  78. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  79. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  80. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  81. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  82. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  83. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  84. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  85. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  86. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  87. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  88. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  89. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  90. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  91. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  92. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  93. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  94. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  95. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  96. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  97. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  98. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  99. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  100. Xu X, et al. 2018. Cell. 175:1336. PubMed
  101. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  102. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  103. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  104. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  105. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  106. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  107. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  108. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  109. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  110. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  111. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  112. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  113. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  114. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  115. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  116. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  117. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  118. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  119. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  120. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  121. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  122. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  123. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  124. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  125. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  126. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  127. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  128. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  129. França TT, et al. 2021. JCI Insight. 6:. PubMed
  130. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  131. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  132. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  133. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  134. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  135. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  136. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  137. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  138. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  139. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  140. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  141. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  142. Port JR, et al. 2020. J Virol. 94:. PubMed
  143. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  144. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  145. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  146. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  147. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  148. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  149. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  150. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  151. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  152. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  153. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  154. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  155. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  156. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  157. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  158. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  159. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  160. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  161. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  162. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  163. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  164. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  165. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  166. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  167. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  168. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  169. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  170. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  171. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  172. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  173. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  174. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  175. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  176. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  177. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  178. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  179. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  180. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  181. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  182. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  183. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  184. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  185. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  186. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  187. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  188. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  189. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  190. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  191. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  192. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  193. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  194. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  195. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  196. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  197. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  198. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  199. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  200. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  201. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  202. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  203. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  204. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  205. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  206. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  207. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  208. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  209. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  210. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  211. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  212. Tao Z, et al. 2022. Cells. 11:. PubMed
  213. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  214. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  215. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  216. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  217. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  218. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  219. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  220. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  221. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  222. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  223. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  224. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  225. Zheng Y, et al. 2022. Transl Res. :. PubMed
  226. Gawish R, et al. 2022. Elife. 11:. PubMed
  227. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  228. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  229. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  230. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  231. Li J, et al. 2021. eLife. 10:00. PubMed
  232. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  233. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  234. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  235. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  236. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  237. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  238. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  239. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  240. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  241. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  242. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  243. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  244. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
RRID
AB_312660 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account